size 36
Title: Cancer Risk in Xeroderma Pigmentosum Heterozygotes
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2003-04-07

Title: Northwestern Ovarian Cancer Early Detection and Prevention Program: A Specimen and Data Study
Phase: NA
Leading organization: Northwestern University
Current Trial Status Date: 2000-01-27

Title: Prospective Registry Study of Neoadjuvant Therapy in Conjunction with Liver Transplantation for Cholangiocarcinoma
Phase: NA
Leading organization: Siteman Cancer Center at Washington University
Current Trial Status Date: 2005-08-12

Title: International Registry for Severe Chronic Neutropenia
Phase: NA
Leading organization: National Center for Research Resources (NCRR)
Current Trial Status Date: 1994-06-01

Title: Collection of Blood, Bone Marrow and Tissue Samples for the Investigation of the Human Immune Response, Lymphoma Biology and HTLV-1 Infection
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 1997-07-10

Title: Evaluation for NCI Surgery Branch Clinical Research Protocols
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 1999-07-01

Title: Psychological Benefits of a Normalized Camping Experience for Children With Cancer
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 1983-02-08

Title: Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 1989-04-20

Title: Biospecimen Acquisition From Human Subjects
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2002-04-19

Title: Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2002-06-19

Title: Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2001-11-28

Title: Characterization of High-Risk Breast Duct Epithelium by Cytology, Breast Duct Endoscopy, and cDNA Gene Expression Profile
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2001-12-13

Title: The Birt Hogg-Dube Syndrome: Identification of the Disease Gene and Characterization of the Predisposition of Renal Cancer
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2020-01-25

Title: Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2002-06-24

Title: Treatment and Natural History Study of Lymphomatoid Granulomatosis
Phase: II
Leading organization: National Cancer Institute
Current Trial Status Date: 2021-02-27

Title: NYU Lung Cancer Biomarker Center
Phase: NA
Leading organization: Laura and Isaac Perlmutter Cancer Center at NYU Langone
Current Trial Status Date: 2001-03-19

Title: Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2004-09-20

Title: Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease With Laboratory and Clinical Correlates of Disease Activity
Phase: II
Leading organization: National Cancer Institute
Current Trial Status Date: 2004-10-28

Title: Open Access Protocol of Targeted Radiotherapy with 131I-Metaiodobenzylguanidine (131I-MIBG) in Patients with Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors
Phase: II
Leading organization: Memorial Sloan Kettering Cancer Center
Current Trial Status Date: 2005-01-11

Title: Preoperative Metabolomic Analysis of Primary Lung Cancer: A Translational Clinical Trial of the Brown Cancer Center
Phase: NA
Leading organization: The James Graham Brown Cancer Center at University of Louisville
Current Trial Status Date: 2005-12-01

Title: Phase II Study of 2-Chlorodeoxyadenosine (2CDA) Followed by Rituximab in Hairy Cell Leukemia
Phase: II
Leading organization: M D Anderson Cancer Center
Current Trial Status Date: 2004-06-10

Title: Collection of Blood, Fluid, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer or Normal Volunteers
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2000-02-17

Title: Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2000-11-21

Title: Prospective Evaluation of Genetic and Epigenetic Alterations in Patients With Thoracic Malignancies
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2005-10-18

Title: Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2002-12-17

Title: Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Diseases
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 1997-07-14

Title: Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 1999-04-27

Title: Urinary and Serum VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2004-06-22

Title: Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2000-02-07

Title: Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia and Myelodysplastic Syndrome
Phase: II
Leading organization: University of Minnesota/Masonic Cancer Center
Current Trial Status Date: 2005-11-21

Title: Genetic and Environmental Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Phase: NA
Leading organization: University Hospitals Cleveland Medical Center
Current Trial Status Date: 2005-10-01

Title: Breast Tissue and Other Biomarkers to Predict Short Term Risk for Breast Cancer
Phase: NA
Leading organization: University of Kansas Cancer Center
Current Trial Status Date: 1989-07-25

Title: Cell Harvest and Preparation for Surgery Branch Adoptive Cell Therapy Protocols
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2021-02-06

Title: Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2004-01-14

Title: Collection of Peripheral Blood and/or Urine From Patients Undergoing Radiation Therapy
Phase: NA
Leading organization: National Cancer Institute
Current Trial Status Date: 2002-02-06

Title: Lymphodepletion plus Adoptive Cell Transfer with or without Dendritic Cell Immunization in Patients with Metastatic Melanoma
Phase: II
Leading organization: M D Anderson Cancer Center
Current Trial Status Date: 2021-07-29